Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women

被引:0
|
作者
Apurva A. Motivala
Patricia A. Rose
H. Myra Kim
Yolanda R. Smith
Catherine Bartnik
Robert D. Brook
Otto Muzik
Claire S. Duvernoy
机构
[1] University of Michigan,From the Division of Cardiovascular Medicine, Department of Internal Medicine
[2] University of Michigan,Center for Statistical Consultation and Research
[3] University of Michigan,Department of Obstetrics and Gynecology
[4] Children’s Hospital of Michigan,Department of Radiology
[5] Detroit Medical Center,undefined
[6] Wayne State University,undefined
[7] Cardiology Section,undefined
[8] Veterans Affairs Ann Arbor Healthcare System,undefined
来源
关键词
Cardiovascular risk; obesity; myocardial blood flow; postmenopausal women;
D O I
暂无
中图分类号
学科分类号
摘要
Background. This study was designed to determine whether overweight or obese status is independently associated with myocardial flow reserve (MFR), an established predictor of cardiovascular mortality, in a group of postmenopausal women with no previous cardiovascular disease. Postmenopausal women are the largest group of overweight and physically inactive individuals in the United States. Increased body mass index (BMI) is consistently associated with increased cardiovascular mortality in this population. Whether this is because of obesity itself or the accompanying increase in cardiovascular risk factors (CRFs) remains controversial.
引用
收藏
页码:510 / 517
页数:7
相关论文
共 50 条
  • [31] IS DECREASE OF BMD A MARKER OF CARDIOVASCULAR RISK IN POSTMENOPAUSAL WOMEN?
    Lukash, Yuliya
    Khozyainova, Natalya
    Tsareva, Valentina
    Romanchenko, Natalia
    Petrushenkova, Oksana
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S98 - S99
  • [32] HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN AND CARDIOVASCULAR RISK
    KARAM, C
    BOURMAYAN, C
    DESNOS, M
    GUEROT, C
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1995, 44 (04): : 195 - 201
  • [33] Hormone replacement therapy in postmenopausal women and cardiovascular risk
    Channer, KS
    English, KM
    LANCET, 1999, 353 (9163): : 1528 - 1528
  • [34] Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome
    Lambrinoudaki, Irene
    MATURITAS, 2011, 68 (01) : 13 - 16
  • [35] Iron statue parameters and cardiovascular risk in postmenopausal women
    Penckofer, S
    Schwertz, DW
    Vahed, S
    Holm, K
    Euler, D
    Bremner, WF
    Hamalis, P
    Sexton, R
    CIRCULATION, 1997, 96 (08) : 1953 - 1953
  • [36] Cardiovascular risk in postmenopausal diabetic women at the Marrakech CHU
    El Latifi, R.
    El Mghari, G.
    El Ansari, N.
    DIABETES & METABOLISM, 2011, 37 : A41 - A41
  • [37] CARDIOVASCULAR RISK PROFILE IN NORMAL AND HYPERTENSIVE POSTMENOPAUSAL WOMEN
    ARANDA, P
    ARANDA, FJ
    LOPEZ, JC
    GERTRUDIS, MA
    PAEZ, M
    RAMIREZ, J
    HYPERTENSION, 1995, 25 (06) : 1403 - 1403
  • [38] Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
    Armeni, Eleni
    Lambrinoudaki, Irene
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (06) : 579 - 590
  • [39] Combined exercise reduces arterial stiffness, blood pressure, and blood markers for cardiovascular risk in postmenopausal women with hypertension
    Son, Won-Mok
    Sung, Ki-Dong
    Cho, Jae-Min
    Park, Song-Young
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (03): : 262 - 268
  • [40] Postmenopausal estrogens and risk of myocardial infarction in diabetic women
    Kaplan, RC
    Heckbert, SR
    Weiss, NS
    Wahl, PW
    Smith, NL
    Newton, KM
    Psaty, BM
    DIABETES CARE, 1998, 21 (07) : 1117 - 1121